Tamización de cáncer colorrectal en población adulta asintomática: revisión sistemática

Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United State, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):90-119. Review.

https://doi.org/10.3322/caac.20063

Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEERMedicare data. Med Care. 2002;40(8 Suppl):IV-104-17.

https://doi.org/10.1097/00005650-200208001-00014

Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editores. Cancer incidence in five continents. Vol. VIII. Lyon: International Agency for Research on Cancer; 2002.

Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner M, et al, editores. SEER Cancer Statistics Review, 1975-2005 [Internet]. Bethesda, MD: National Cancer Institute; 2008 [Citado: 29 diciembre 2009]. Disponible en: http://seercancergov/csr/1975_2005/2008.

Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide [computer program]. IARC CancerBase No. 5, version 2,0. Lyon: IARC Press; 2004.

Cendales R. Estimación de los casos nuevos de cáncer en Colombia en el año 2005 [tesis de especialidad]. [Bogotá]: Universidad Nacional de Colombia; 2005.

Ángel Arango L, Giraldo Ríos A, Pardo CE. Mortalidad por cánceres del aparato digestivo en Colombia entre 1980 y 1998, análisis de tendencias y comparación regional. Rev Fac Med (Colombia). 2004;52(1):19-37.

Instituto Nacional de Cancerología. Anuario Estadístico 2004. Bogotá: Medilegis; 2005.

Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar M, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594-642.

https://doi.org/10.1053/gast.1997.v112.agast970594

Tsai CJ, Lu DK. Small colorectal polyps: histopathology and clinical significance. Am J Gastroenterol. 1995;90(6): 988-94.

Eide TJ. Natural history of adenomas. World J Surg. 1990;15(1):3-6.

https://doi.org/10.1007/BF01658952

Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987;93(5):1009-13.

https://doi.org/10.1016/0016-5085(87)90563-4

Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):132-41. Review.

https://doi.org/10.7326/0003-4819-137-2-200207160-00015

Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343(3):169-74.

https://doi.org/10.1056/NEJM200007203430302

Anderson BO, Braun S, Lim S, Smith RA, Taplin S, Thomas DB, et al. Early detection of breast cancer in countries with limited resources. Breast J. 2003;9 Suppl 2:S51-9.

https://doi.org/10.1046/j.1524-4741.9.s2.4.x

AGREE Collaboration. Appraisal of guidelines for research & evaluation (AGREE) instrument [Internet]. London: The AGREE Collaboration; 2001 [Citado: 24 noviembre 2008]. 22p. Disponible en: http://www.agreecollaboration.org/instrument/.

Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developer's handbook [Internet]. Edinburgh: SIGN; 2008 [Citado: 24 noviembre 2008]. 112 p. Disponible en: http://www.sign.ac.uk/guidelines/fulltext/50/index.html.

Smith RA, Cokkinides V, Eyre HJ; American Cancer Society. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53(1):27-43.

https://doi.org/10.3322/canjclin.53.1.27

McLeod RS; Canadian Task Force on Preventive Health Care. Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol. 2001;15(10):647-60.

https://doi.org/10.1155/2001/284746

National Health and Medical Research Council, Australian Cancer Network. Guidelines for the prevention, early detection and management of Colorectal Cancer (CRC). Canberra: NHMRC; 1999 [Revocado: 2005].

National Medical Research Council. Clinical Practice Guideline. Singapore: Singapore Ministry of Health; 2004.

Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale--Update based on new evidence. Gastroenterology. 2003;124(2):544-60.

https://doi.org/10.1053/gast.2003.50044

Rubiano Vinueza J, Mariño Rugeles G, Kestenberg A. Guías de práctica clínica basadas en la evidencia: Tamizaje en cáncer digestivo. Bogotá: Proyecto ISS - ASCO- FAME; 1999.

Grupo de trabajo de la guía de práctica clínica de prevención del cáncer colorrectal. Guía de práctica clínica. Barcelona; Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano; 2004. Programa de Elaboración de Guías de Práctica Clínica en Enfermedades Digestivas desde la Atención Primaria a la Especializada: 4.

Institute for Clinical Systems Improvement. Health Care Guidelines: Colorectal cancer screening. 11th ed. Bloomington, MN: Institute for Clinical Systems Improvement; 2006.

Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638-58.

https://doi.org/10.7326/0003-4819-149-9-200811040-00245

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82-90.

https://doi.org/10.1053/j.gastro.2008.03.040

Paz Valiñas L, Atienza Merino G. Evaluación de la eficacia y efectividad del cribado poblacional del cáncer colorrectal. Aplicabilidad en el Sistema Nacional de Salud. Santiago de Compostela: Servicio Galego de Saúde, Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia, avalia-t; 2002.

Moayyedi P, Achkar E. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol. 2006;101(2):380-4.

https://doi.org/10.1111/j.1572-0241.2006.00537.x

Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;(1):CD001216. Review.

https://doi.org/10.1002/14651858.CD001216.pub2

Faivre J, Dancourt V, Lejeune C, Tazi M, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126(7):1674-80.

https://doi.org/10.1053/j.gastro.2004.02.018

Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol. 2004;39(9):846-51.

https://doi.org/10.1080/00365520410003182

Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50(1):29-32.

https://doi.org/10.1136/gut.50.1.29

Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lance. 1996;348(9040):1472-7.

https://doi.org/10.1016/S0140-6736(96)03386-7

Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ. 1998;317(7158):559-65.

https://doi.org/10.1136/bmj.317.7158.559

Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603-7.

https://doi.org/10.1056/NEJM200011303432203

Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg. 2008;95(8):1029-36.

https://doi.org/10.1002/bjs.6136

Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink J, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100(7):1103-10.

https://doi.org/10.1038/sj.bjc.6604961

Medical Services Advisory Committee. Faecal occult blood testing for population health screening. MSAC Reference 18. Assessment Report. Canberra: MSAC; 2004.

De Laet C, Neyt M, Vinck I, Lona M, Cleemput I, Van De Sande S. Health Technology Assessment. Colorectale Kankerscreening: wetenschappelijke stand van zaken en budgetimpact voor België. Brussel: Health Technology Assessment (HTA); 2006.

Hoff G, Grotmol T, Skovlund E, Bretthauer M; Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009;338:b1846.

https://doi.org/10.1136/bmj.b1846

Niv Y, Hazazi R, Levi Z, Fraser G. Screening colonoscopy for colorectal cancer in asymptomatic people: a meta-analysis. Dig Dis Sci. 2008;53(12):3049-54.

https://doi.org/10.1007/s10620-008-0286-y

Smith RA, Cokkinides V, Eyre HJ; American Cancer Society. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004;54(1):41-52.

https://doi.org/10.3322/canjclin.54.1.41

Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003;289(10):1288-96.

https://doi.org/10.1001/jama.289.10.1288

Mandel JS, Bond JH, Bradley M, Snover DC, Church TR, Williams S, et al. Sensitivity, specificity and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology. 1989;97(3):597-600.

https://doi.org/10.1016/0016-5085(89)90629-X

Kerr J, Broadstock M, Day P, Hogan S. Effectiveness and cost-effectiveness of population screening for colorectal cancer. A systematic review of the literature. Christchurch, New Zeland: New Zeland Health Technology Assessment; 2005.

Young GP, St John DJ, Winawer SJ, Rozen P; WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97(10):2499-507.

https://doi.org/10.1016/S0002-9270(02)04404-0

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 Suppl):273S-309S.

https://doi.org/10.1016/S0197-2456(00)00098-2

Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med. 2005;142(8):635-50.

https://doi.org/10.7326/0003-4819-142-8-200504190-00013

Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med. 2000;342(24):1766-72.

https://doi.org/10.1056/NEJM200006153422401

Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M; Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48(6):812-5.

https://doi.org/10.1136/gut.48.6.812

Paz-Valiñas L, Atienza Merino G. [Population screening for colorectal cancer: a systematic review]. Gastroenterol Hepatol. 2004;27(8):450-9. Review. Spanish.

https://doi.org/10.1016/S0210-5705(03)70502-0

Lewis JD, Ng K, Hung KE, Bilker WB, Berlin JA, Brensinger C, et al. Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med. 2003;163(4):413-20.

https://doi.org/10.1001/archinte.163.4.413